本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 1994/3/111 分钟阅读
Clinical Trial Design Issues of Liposomal Antifungal Agents; Public Workshop
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration (FDA) in conjunction with the National Institute of Allergy and Infectious Diseases (NIAID) is announcing a public workshop on clinical trial design issues of liposomal antifungal agents. The workshop will enable experts in the field of fungal diseases to exchange ideas regarding clinical trials of liposomal antifungal agents. While the workshop is not intended to result in consensus among the participants or formulation of agency policy, discussions regarding these agents may provide assistance to pharmaceutical sponsors in designing appropriate study protocols and expediting drug development.
来源原始语言: Federal Register — Health and Human Services打开原始公告 →